Abhijit Narvekar

Executive Medical Director, Clinical Development and Medical Affairs

Abhijit Narvekar is the Executive Medical Director, Clinical Development and Medical Affairs, at Aura. Abhijit brings more than 10 years of progressive clinical development experience in Ophthalmology, with a particular focus in global clinical trial management. Prior to joining Aura, Abhijit was a Director and Global Clinical Development Lead at Shire Plc where he spearheaded the global, Phase 3 ophthalmology program in support of two ocular disease indications. He previously held various clinical development positions of increasing responsibility at Alcon, a division of Novartis where he managed and supported multiple ophthalmology programs encompassing early & late clinical development and life cycle management of anti-allergy, anti-inflammatory & anti-infective products including Pataday®, Pazeo®, Ilevro® and Durezol®. Abhijit began his professional career in the neuroscience field where he held clinical, academic and research positions before transitioning to ophthalmology. Abhijit received his M.S. in applied cognition and neuroscience from the University of Texas at Dallas, his D.P.M from the College of Physicians and Surgeons of Bombay, India, and a M.B.B.S from the Seth GS Medical College and KEM Hospital at The University of Mumbai, India.